Neuropace Inc (NPCE)

EBITDA Growth

32.44%

Quarterly · Period ending:

NPCE logo

NPCE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported32.44%
NPCE Quarterly EBITDA YoY % (-88.12% → 32.44%)
High-resolution chart · PNG

NPCE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neuropace Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
32.4448%
-17.1364%
76.7165%
27.9532%
-24.6941%
36.3549%
26.6667%
39.6101%
25.6519%
22.0961%
57.9439%
48.9278%
34.6543%
9.7308%
3.4164%
-47.8486%
-54.0363%
-28.9241%
-228.5285%
-400.9724%
-33.7893%
-88.118%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.